miR‑21‑5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3.
about
miR‑21‑5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
miR‑21‑5p confers doxorubicin ...... s by targeting PTEN and TIMP3.
@en
miR‑21‑5p confers doxorubicin ...... s by targeting PTEN and TIMP3.
@nl
type
label
miR‑21‑5p confers doxorubicin ...... s by targeting PTEN and TIMP3.
@en
miR‑21‑5p confers doxorubicin ...... s by targeting PTEN and TIMP3.
@nl
prefLabel
miR‑21‑5p confers doxorubicin ...... s by targeting PTEN and TIMP3.
@en
miR‑21‑5p confers doxorubicin ...... s by targeting PTEN and TIMP3.
@nl
P2093
P2860
P356
P1476
miR‑21‑5p confers doxorubicin ...... s by targeting PTEN and TIMP3.
@en
P2093
Jianping Xiong
Ling Zhang
Xiaojun Xiang
P2860
P304
P356
10.3892/IJMM.2018.3405
P577
2018-01-18T00:00:00Z